BIORESTORATIVE THERAPIES, INC. Deferred Tax Assets, Valuation Allowance
BIORESTORATIVE THERAPIES, INC. (BRTX) had Deferred Tax Assets, Valuation Allowance of $22.58 million as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-03-26
- 2025-12-31: Deferred Tax Assets, Valuation Allowance $22.58M.
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $29.43M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $31.84M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $27.78M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2025-12-31 | $22.58M 10-K · filed 2026-03-26 |
| 2024-12-31 | $29.43M 10-K · filed 2026-03-26 |
| 2023-12-31 | $31.84M 10-K · filed 2025-03-28 |
| 2022-12-31 | $27.78M 10-K/A · filed 2024-06-11 |
| 2021-12-31 | $21.95M 10-K · filed 2023-03-27 |
| 2020-12-31 | $14.10M 10-K · filed 2022-03-30 |
| 2019-12-31 | $12.01M 10-K · filed 2021-04-30 |
| 2018-12-31 | $8.18M 10-K · filed 2021-03-18 |
| 2017-12-31 | $5.39M 10-K · filed 2019-03-29 |
| 2016-12-31 | $6.68M 10-K · filed 2018-04-02 |
| 2015-12-31 | $3.41M 10-K · filed 2017-03-22 |
| 2014-12-31 | $6.33M 10-K · filed 2016-03-30 |
| 2013-12-31 | $6.37M 10-K · filed 2015-03-31 |
| 2012-12-31 | $4.74M 10-K · filed 2014-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |